|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 374.80 SEK | -0.90% |
|
-6.35% | -3.10% |
| 13/01 | Carnegie raises target price for Bonesupport to SEK 450 (390), reiterates Buy - BN | FW |
| 08/01 | First public blank in years in Bonesupport | FW |
| Capitalization | 2.47TCr 218.59Cr 214.3Cr 200.93Cr 179.8Cr 315.04Cr 19TCr 355.25Cr 914.66Cr 7.76TCr 820.6Cr 802.92Cr 34TCr | P/E ratio 2024 * |
194x | P/E ratio 2025 * | 80.9x |
|---|---|---|---|---|---|
| Enterprise value | 2.45TCr 217.08Cr 212.83Cr 199.55Cr 178.56Cr 312.87Cr 19TCr 352.8Cr 908.35Cr 7.7TCr 814.94Cr 797.38Cr 34TCr | EV / Sales 2024 * |
27x | EV / Sales 2025 * | 18.1x |
| Free-Float |
82.77% | Yield 2024 * |
-
| Yield 2025 * | 0.31% |
More valuation ratios
* Estimated data
More news
Last Transcript: Bonesupport Holding AB
More recommendations
More press releases
More news
| 1 day | -0.90% | ||
| 1 week | -6.35% | ||
| Current month | -3.10% | ||
| 1 month | +8.51% | ||
| 3 months | +12.35% | ||
| 6 months | +32.44% | ||
| Current year | -3.10% |
1 week
356.60
405.80
1 month
355.80405.80
Current year
356.60405.80
1 year
172.50405.80
3 years
34.20405.80
5 years
19.05405.80
10 years
9.04405.80
| Director | Title | Age | Since |
|---|---|---|---|
Emil Billbäck
CEO | Chief Executive Officer | 55 | 01/03/2018 |
Hakan Johansson
DFI | Director of Finance/CFO | 62 | 01/11/2018 |
| Chief Operating Officer | 50 | 01/12/2021 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 01/01/2010 | |
| Chairman | 68 | 15/12/2016 | |
| Chairman | 70 | 14/05/2019 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.75% | 4 M€ | -1.04% | ||
| 0.00% | 0 M€ | -3.35% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.90% | -6.35% | +85.54% | +846.46% | 221.51Cr | ||
| +0.26% | -1.28% | -2.94% | -0.37% | 8.48TCr | ||
| +1.20% | +7.66% | +36.02% | +18.09% | 4.83TCr | ||
| -1.97% | +0.21% | +126.98% | +106.31% | 3.79TCr | ||
| +0.91% | -1.33% | -39.47% | -33.35% | 2.17TCr | ||
| +2.59% | +3.94% | +15.35% | -1.70% | 1.36TCr | ||
| -0.58% | +0.24% | -28.22% | -23.96% | 1.28TCr | ||
| +0.87% | -3.13% | -6.72% | -37.82% | 1.17TCr | ||
| -3.39% | -6.12% | +215.40% | +421.51% | 1.12TCr | ||
| +34.07% | +51.92% | +91.67% | +220.22% | 1.01TCr | ||
| Average | +3.30% | +0.63% | +49.36% | +151.54% | 2.54TCr | |
| Weighted average by Cap. | +1.43% | +1.18% | +34.35% | +47.90% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 91Cr 8.03Cr 7.88Cr 7.39Cr 6.61Cr 12Cr 696.57Cr 13Cr 34Cr 285.17Cr 30Cr 30Cr 1.27TCr | 133.8Cr 12Cr 12Cr 11Cr 9.75Cr 17Cr 1.03TCr 19Cr 50Cr 420.88Cr 45Cr 44Cr 1.87TCr |
| Net income | 13Cr 1.13Cr 1.11Cr 1.04Cr 92.94L 1.63Cr 98Cr 1.84Cr 4.73Cr 40Cr 4.24Cr 4.15Cr 178.14Cr | 31Cr 2.71Cr 2.65Cr 2.49Cr 2.23Cr 3.9Cr 234.63Cr 4.4Cr 11Cr 96Cr 10Cr 9.94Cr 426.71Cr |
| Net Debt | -17Cr -1.51Cr -1.48Cr -1.39Cr -1.24Cr -2.17Cr -130.63Cr -2.45Cr -6.31Cr -53Cr -5.66Cr -5.53Cr -237.57Cr | -41Cr -3.66Cr -3.59Cr -3.37Cr -3.01Cr -5.28Cr -317.39Cr -5.95Cr -15Cr -129.94Cr -14Cr -13Cr -577.23Cr |
More financial data
* Estimated data
Employees
131
Sector
Pharmaceuticals
Calendar
25/02/2025
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/25/13 | 374.80 kr | -0.90% | 93,572 |
| 10/25/10 | 378.20 kr | +3.33% | 348,667 |
| 09/25/09 | 366.00 kr | -7.39% | 346,944 |
| 08/25/08 | 395.20 kr | -0.85% | 173,532 |
Delayed Quote Nasdaq Stockholm, January 13, 2025 at 10:30 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
374.80SEK
Average target price
402.33SEK
Spread / Average Target
+7.35%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BONEX Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition